2162.HK
2162.HK
KYG5252B1023
KEYMED BIO-B
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 716.313.000 428.124.000
67.3%
Cost of Revenue 88.048.000 12.200.000
621.7%
Gross Profit 628.265.000 415.924.000
51.1%
1.175.954.000 1.002.088.000
17.4%
Operating Income -547.689.000 -586.164.000
6.6%
Pretax Income -520.723.000 -508.647.000
2.4%
Net Income Common Stockholders -522.641.000 -515.241.000
1.4%
-- --
--
-- --
--
ende